MoxyTrip-IV is a potent antibiotic belonging to the fluoroquinolone class. It is primarily used to treat severe bacterial infections that are resistant to other treatments. It works by inhibiting the DNA enzymes (DNA gyrase and topoisomerase IV) that bacteria need to replicate and repair themselves, effectively killing the infection. This intravenous (IV) form is commonly used in hospital settings for serious conditions such as community-acquired pneumonia, complicated skin and skin structure infections, and intra-abdominal infections.

Doctors often prescribe it when a patient cannot take oral medication or when the infection is aggressive. Because it is a broad-spectrum antibiotic, it is effective against both Gram-positive and Gram-negative bacteria. Common side effects may include nausea, dizziness, or headache. It is vital to complete the full course as prescribed to prevent the development of antibiotic-resistant bacteria. Patients with a history of tendon issues or certain heart rhythm conditions should use this only under strict medical supervision.